Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06863363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults

StatusNot Yet Recruiting
PhasePhase 4
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to evaluate the efficacy and safety of PEG-rhGH Injection combined with Semaglutide Injection versus Semaglutide Injection monotherapy in improving body composition (lean body mass, fat mass, etc.) in non-diabetic obese adults, while also analyzing changes in body weight, blood glucose, and other metabolic parameters.
Trial Details
NCT Number NCT06863363
Lead Sponsor Shanghai Zhongshan Hospital
Conditions
(from sponsor)		 Non-diabetic Obesity
Enrollment 212 participants
Updated on ClinicalTrials.gov